Related Experiment Video
Updated: Jul 31, 2025

12:03
Fertility Preservation in Patients with Severe Ovarian Dysfunction
Published on: March 25, 2021
4.7K
A sharing oocyte donation program: a 15-year cohort stud
Talita Colombo1,2, Marta Ribeiro Hentschke2,3, Mariangela Badalotti2,3
1Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil.
JBRA Assisted Reproduction
|May 3, 2023
Summary
Oocyte donation offers comparable success rates for both donors and recipients, highlighting the critical role of oocyte quality in fertility treatments. This suggests oocyte-sharing programs are a viable and encouraging option for achieving pregnancy.
Area of Science:
- Reproductive Medicine
- In Vitro Fertilization (IVF)
- Oocyte Donation
Background:
- Oocyte donation is a key pathway for individuals to access in vitro fertilization (IVF).
- It presents a viable option for recipients seeking pregnancy through assisted reproductive technologies.
Purpose of the Study:
- To evaluate and compare clinical and laboratory outcomes between oocyte donors and recipients.
- To assess the effectiveness of oocyte donation cycles in achieving successful pregnancies.
Main Methods:
- A retrospective cohort study analyzed 586 fresh oocyte donation cycles from 01/2002 to 12/2017.
- Outcomes from 290 donor cycles and 296 recipient cycles were analyzed, including 473 fresh embryo transfers.
- Statistical analysis involved Chi-square, Fisher's exact, Mann-Whitney U, and Student t-tests, with multivariate logistic regression.
Main Results:
- Fertilization rates were similar (72.0% donor vs. 74.6% recipient, p<0.001).
- Implantation rates (46.2% vs. 48.5%), clinical pregnancy rates (41.9% vs. 37.7%), and live birth rates (33.3% vs. 37.7%) were comparable between donors and recipients.
- Demographic and clinical factors in young, healthy donors/recipients did not significantly impact pregnancy outcomes.
Conclusions:
- Oocyte donation provides good and comparable results for both donors and recipients.
- Oocyte quality appears to be the primary determinant of success in intracytoplascitic sperm injection (ICSI) treatments.
- Oocyte-sharing programs are recommended as fair and effective options for fertility treatment.

